| [1] |
Zhu Weijian, He Ying, Huang Mufang, Fu Shezhu, Wang Xiaoqi, Li Zhixin, Chen Lijun, Li Xiaoliang.
Change of miR-223-3p level in peripheral blood of β-thalassemia treated with thalidomide and corresponding clinical value
[J]. Clinical Focus, 2022, 37(6): 515-518.
|
| [2] |
Wen Xue, Zhang Zhihua, Zhang Rongjuan, Hao Changlai.
Hereditary spherocytosis caused by SPTB gene hybrid mutation: a case report
[J]. Clinical Focus, 2021, 36(11): 1019-1023.
|
| [3] |
Li Yingmei;Sun Hui.
Current status of diagnosis and treatment of autoimmune hemolytic anemia
[J]. Clinical Focus, 2015, 30(10): 1087-1091.
|
| [4] |
WU Yu;XU Juan.
Advances in the treatment of hemolytic anemia
[J]. Clinical Focus, 2014, 29(10): 1087-1.09011e+007.
|
| [5] |
.
[J]. CLINICAL FOCUS, 2011, 26(5): 382-0.
|
| [6] |
SUN Li-xia;YANG Jian-zhu;ZHANG Jin-qiao;LV Hong-yan;SONG Xiao-ning;WANG Jin-kai.
Alteration of transforming growth factor-β1 and interleukin-10 in patients with autoimmune hemolytic anemia
[J]. CLINICAL FOCUS, 2009, 24(19): 1702-1704.
|
| [7] |
.
[J]. CLINICAL FOCUS, 2008, 23(12): 902-903.
|
| [8] |
.
[J]. CLINICAL FOCUS, 2008, 23(11): 827-828.
|
| [9] |
.
[J]. CLINICAL FOCUS, 2008, 23(5): 369-370.
|
| [10] |
.
[J]. CLINICAL FOCUS, 2007, 22(12): 901-903.
|
| [11] |
.
[J]. CLINICAL FOCUS, 2006, 21(20): 1454-1454.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2006, 21(12): 855-855.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2004, 19(18): 1077-1078.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2004, 19(6): 346-346.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2004, 19(4): 208-209.
|
